MARKET

HCWB

HCWB

Hcw Biologics Inc.
NASDAQ
0.9706
-0.1634
-14.41%
After Hours: 1.090 +0.119 +12.30% 19:50 12/31 EST
OPEN
1.170
PREV CLOSE
1.134
HIGH
1.170
LOW
0.9532
VOLUME
274.45K
TURNOVER
--
52 WEEK HIGH
41.20
52 WEEK LOW
0.9532
MARKET CAP
2.62M
P/E (TTM)
-0.0695
1D
5D
1M
3M
1Y
5Y
1D
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance
TipRanks · 12/31/2025 17:58
HCW Biologics Raises $3.8 Million Through Warrant Exercise and Equity Issuance
Reuters · 12/31/2025 17:37
Weekly Report: what happened at HCWB last week (1222-1226)?
Weekly Report · 12/29/2025 10:15
HCW Biologics (HCWB) Receives a Buy from Maxim Group
TipRanks · 12/23/2025 13:25
Weekly Report: what happened at HCWB last week (1215-1219)?
Weekly Report · 12/22/2025 10:15
U.S. RESEARCH ROUNDUP-Comerica, Heico, Walmart
Reuters · 12/22/2025 07:49
Weekly Report: what happened at HCWB last week (1208-1212)?
Weekly Report · 12/15/2025 10:22
Weekly Report: what happened at HCWB last week (1201-1205)?
Weekly Report · 12/08/2025 10:20
More
About HCWB
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

Webull offers Hcw Biologics Inc stock information, including NASDAQ: HCWB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCWB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCWB stock methods without spending real money on the virtual paper trading platform.